UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between immunotherapy and chemotherapy clinical trials and research opportunities
Harnesses the immune system to fight cancer. Checkpoint inhibitors (pembrolizumab, nivolumab) have transformed outcomes in many cancers. Generally fewer side effects but can cause immune-related adverse events.
Traditional cytotoxic treatment that kills rapidly dividing cells. Well-established across virtually all cancer types. More predictable response patterns but broader side effect profile.
Immunotherapy can produce durable long-term responses but only works in a subset of patients. Chemotherapy is more broadly active but responses are typically temporary.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
